Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: Is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?

Journal of Interventional Cardiac Electrophysiology

Volumn 40, Issue 2, 2014, Pages 161-168

  Pillarisetti, Jayasree ^a   Reddy, Namratha ^a   Biria, Mazda ^a   Ryschon, Kay ^b   Nagarajan, Darbhamulla ^a   Murray, Caroline ^a   Atkins, Donita ^a   Bommana, Sudharani ^a   Reddy, Madhu Yeruva ^a   DiBiase, Luigi ^c   Pimentel, Rhea ^a   Berenbom, Loren ^a   Dawn, Buddhadeb ^a   Natale, Andrea ^c   Lakkireddy, Dhanunjaya ^a  

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

^b Ryschon Consulting LLC   (United States)

^c TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

Author keywords

Brain natriuretic peptide (BNP); Catheter ablation and atrial fibrillation; Rhythm

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; BIOLOGICAL MARKER;

ABLATION CATHETER; ADULT; AGED; ARTICLE; CARDIAC MAPPING SYSTEM; CATHETER ABLATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART RATE; HEART VENTRICLE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; INTRACARDIAC ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MAPPING CATHETER; MIDDLE AGED; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; SINUS RHYTHM; TREATMENT FAILURE; ATRIAL FIBRILLATION; BLOOD; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RECURRENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84905578132     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-014-9898-7     Document Type: Article

References (33)

1. Levin, E. R., Gardner, D. G., & Samson, W. K. (1998). Natriuretic peptides. New England Journal of Medicine, 339, 321-328. (Pubitemid 28366422)
2. Silvet, H., Young-Xu, Y., Walleigh, D., & Ravid, S. (2003). Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. American Journal of Cardiology, 92, 1124-1127. (Pubitemid 37329544)
3. Tsuchida, K., & Tanabe, K. (2004). Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion. Journal of Cardiology, 44, 1-11.
4. Beck-da-Silva, L., de Bold, A., Fraser, M., Williams, K., & Haddad, H. (2004). Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Canadian Journal of Cardiology, 20, 1245-1248. (Pubitemid 39545560)
5. Vinch, C. S., Rashkin, J., Logsetty, G., Tighe, D. A., Hill, J. C., Meyer, T. E., et al. (2004). Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology, 102, 188-193. (Pubitemid 39370532)
6. Ohta, Y., Shimada, T., Yoshitomi, H., Inoue, S., Murakami, Y., Shimizu, H., et al. (2001). Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Canadian Journal of Cardiology, 17, 415-420. (Pubitemid 32492432)
7. Haissaguerre, M., Jais, P., Shah, D. C., et al. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England Journal of Medicine, 339, 659-666. (Pubitemid 28402090)
8. Jais, P., Sanders, P., Hsu, L. F., Hosini, M., & Haissaguerre, M. (2005). Catheter ablation for atrial fibrillation. Heart, 91, 7-9. (Pubitemid 39664979)
9. Kurosaki, K., Tada, H., Hashimoto, T., Ito, S., Miyaji, K., Naito, S., et al. (2007). Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation. Circulation Journal, 71, 313-320. (Pubitemid 46409531)
10. Date, T., Yamane, T., Inada, K., Matsuo, S., Miyanaga, S., Sugimoto, K., et al. (2006). Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation. Heart, 92, 1623-1627. (Pubitemid 44629169)
11. Yamada, T., Murakami, Y., Okada, T., Yoshida, N., Toyama, J., Yoshida, Y., et al. (2007). Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation. Europace, 9(9), 770-774. (Pubitemid 47371652)
12. Yamada, T., Murakami, Y., Okada, T., Yoshida, N., Toyama, J., Yoshida, Y., et al. (2008 Mar). Plasma brain natriuretic peptide level after hybrid therapy with pulmonary vein isolation and antiarrhythmic drugs for atrial fibrillation. International Heart Journal, 49(2), 143-151. (Pubitemid 351902978)
13. Hussein, A. A., Saliba, W. I., Martin, D. O., Shadman, M., Kanj, M., Bhargava, M., et al. (2011). Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation. Circulation, 123(19), 2077-2082.
14. Shin, D. I., Deneke, T., Gorr, E., Anders, H., Buenz, K., Paesler, M., et al. (2009). Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic peptide plasma levels. Indian Pacing Electrophysiology Journal, 9, 241-246.
15. Hwang, H. J., Son, J.W., Nam, B. H., Joung, B., Lee, B., Kim, J. B., et al. (2009). Incremental predictive value of pre-procedural Nterminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation. Clinical Research in Cardiology, 98, 213-218.
16. Mohanty, S., Mohanty, P., Di Biase, L., Rong, B., Burkhardt, D., Gallinghouse, J. G., et al. (2011). Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation. Journal of Cardiovascular Electrophysiology, 22(8), 858-865.
17. McKie, P. M., & Burnett, J. C., Jr. (2005). B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities. Mayo Clinic Proceedings, 80, 1029-1036.
18. Redfield, M. M., Rodeheffer, R. J., Jacobsen, S. J., Mahoney, D.W., Bailey, K. R., & Burnett, J. C., Jr. (2002). Plasma brain natriuretic peptide concentration: impact of age and gender. Journal of the American College of Cardiology, 40, 976-982. (Pubitemid 34994995)
19. Callahan, T. D., 4th, Di Biase, L., Horton, R., Sanchez, J., Gallinghouse, J. G., & Natale, A. (2009). Catheter ablation of atrial fibrillation. Cardiology Clinics, 27, 163-178.
20. http://www.biosite.com/products/bnp.aspx. last accessed 4/3/10
21. Oral, H., Knight, B. P., Ozaydin, M., Tada, H., Chugh, A., Hassan, S., et al. (2002). Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. Journal of the American College of Cardiology, 40, 100-104. (Pubitemid 34701383)
22. Gerbes, A. L., Dagnino, L., Nguyen, T., & Nemer, M. (1994). Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. Journal of Clinical Endocrinology and Metabolism, 78, 1307-1311. (Pubitemid 24180996)
23. Wasywich, C. A., Webster, M.W., Richards, A.M., & Stewart, R. A. (2006). Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease. American Journal of Cardiology, 97, 1068-1072.
24. Mukoyama, M., Nakao, K., Saito, Y., Ogawa, Y., Hosoda, K., Suga, S., et al. (1990). Human brain natriuretic peptide, a novel cardiac hormone. Lancet, 335, 801-802. (Pubitemid 20106739)
25. Inoue, S., Murakami, Y., Sano, K., Katoh, H., & Shimada, T. (2000). Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. Journal of Cardiac Failure, 6, 92-96. (Pubitemid 30439442)
26. Qi, W. F., Kjekshus, H. F., Klinge, R. F., kjekshus, J. K., & Hall, C. (2000). Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs. Acta Physiologica Scandinavica, 169, 95-102.
27. Magioncalda, A., Sartini, M., Costaguta, C., Castellaneta, M., Schenone, E., Tognoni, E., et al. (2008). The utility of assaying the N-terminal of brain natriuretic peptide precursor (NT pro-BNP) to predict the clinical outcome in patients with supraventricular tachyarrhythmias observed and treated in the emergency room. Recenti Progressi in Medicina, 99, 141-145. (Pubitemid 351548232)
28. Chen, L., Wei, T., Zeng, C., Chen, Q., Shi, Z., & Wang, L. (2005). Effect of radio frequency catheter ablation on plasma B-type natriuretic peptide. Pacing and Clinical Electrophysiology, 28(3), 200-204. (Pubitemid 40393107)
29. Vanga, S., Pillarisetti, J., Biria, M., Rajoli, S., Pimentel, R., Lakkireddy, D. (2010). Overcoming Fluid Overload After Atrial Fibrillation Ablation with an Open Irrigated Catheter: Role of Scheduled Diuresis and Electrolyte Replacement. Heart Rhythm Supplement 7:pO-06 58. (Abs)
30. Li, J., & Wang, L. (2006). B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart and Vessels, 21, 137-140.
31. Kim, B. J., Hwang, S. J., Sung, K. C., et al. (2007). Assessment of factors affecting plasma BNP levels in patients with chronic atrial fibrillation and preserved left ventricular systolic function. International Journal of Cardiology, 118, 145-150. (Pubitemid 46601639)
32. Yamada, T., Murakami, Y., Okada, T., Kim, B. S., Kang, J. H., Lee, M. H., et al. (2006). Plasma atrial natriuretic peptide and brain natriuretic peptide levels after radiofrequency catheter ablation of atrial fibrillation. American Journal of Cardiology, 97, 1741-1744. (Pubitemid 43817862)
33. Wazni, O. M., Martin, D. O., Marrouche, N. F., Okamoto, M., Shimizu, T., Toyama, J., et al. (2004). Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation, 110, 124-127. (Pubitemid 38924579)